About Borderroot
An independent resource on ibogaine care near the border—built for careful questions, plain language, and decisions that deserve time.
Why we exist
Borderroot exists because people considering cross-border treatment information often face a mix of urgent decisions, uneven claims, and unfamiliar systems. We are an independent resource on ibogaine-related care in Tijuana and the wider cross-border treatment landscape. Our purpose is to help people understand evidence, safety considerations, regulation, and informed questions without presenting ourselves as a provider.
Our starting point is the wider Borderroot resource on ibogaine care near the border: a place for families and individuals who need orientation before they decide what, if anything, comes next. The work is organized to make important distinctions easier to see and uncertainty easier to name.
Our editorial approach
We look to registries, published literature, official sources, and primary material where available. For example, the ClinicalTrials.gov study registry provides a public way to inspect registered research records rather than relying only on summaries.
We distinguish between what a source states, what a source can support, and what remains unclear. Our service materials explain the ways Borderroot organizes practical information so readers can find the type of context they need without treating it as individualized guidance.
Evidence does not remove uncertainty. We use plain language, identify gaps where they matter, and point readers toward established research concepts such as the evidence-based medicine framework when discussing how evidence and judgment are weighed.
What we cover
Borderroot organizes information around cross-border treatment landscapes, questions to ask, safety awareness, policy context, and the limits of publicly available information. It is designed for people considering ibogaine-related travel or care, and for families looking for a steadier way to understand the terrain.
Some readers are comparing regional pathways, including Canadian treatment cost considerations, while others are trying to understand the broader Mexico treatment landscape. Those are different questions, and they should not be compressed into a single answer.
“Useful information should make a difficult question more legible—not make a decision for someone.”
We also recognize that people may be weighing different contexts, such as United States treatment considerations, looking at a clinic comparison framework, or trying to find treatment centers closer to home. Borderroot does not endorse or refer providers.
Provenance and principles
Information is reviewed with attention to source quality, dates, scope, and whether a source is primary, official, or interpretive. For public-health context, we favor material that can be checked against organizations such as the World Health Organization, while recognizing that a general source does not replace individual medical or legal advice.
Readers may also encounter comparisons such as ibogaine and mushrooms. We approach such material as context for questions, not as a basis for recommendations, diagnoses, or decisions.
Independent by design
Borderroot is an independent editorial resource, not a clinic, medical provider, licensed treatment center, or legal authority. Nothing here is medical or legal advice. We do not make treatment decisions, assess suitability, or provide referrals.
Our role is narrower and intentional: to provide organized context so readers can prepare thoughtful questions and consult qualified professionals where appropriate.